tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BioCryst price target lowered to $25 from $27 at Citizens JMP
PremiumThe FlyBioCryst price target lowered to $25 from $27 at Citizens JMP
1M ago
BioCryst Pharmaceuticals Shines in Q3 Earnings Call
Premium
Company Announcements
BioCryst Pharmaceuticals Shines in Q3 Earnings Call
1M ago
BioCryst’s Strong Growth and Strategic Moves Reinforce Buy Rating
Premium
Ratings
BioCryst’s Strong Growth and Strategic Moves Reinforce Buy Rating
1M ago
BioCryst raises FY25 net ORLADEYO revenue view to $590M-$600M
PremiumThe FlyBioCryst raises FY25 net ORLADEYO revenue view to $590M-$600M
1M ago
BioCryst reports Q3 adjusted EPS 16c, consensus 8c
Premium
The Fly
BioCryst reports Q3 adjusted EPS 16c, consensus 8c
1M ago
BioCryst Pharmaceuticals (BCRX) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
BioCryst Pharmaceuticals (BCRX) Q3 Earnings Cheat Sheet
1M ago
BioCryst reinstated with a Buy at TD Cowen
PremiumThe FlyBioCryst reinstated with a Buy at TD Cowen
2M ago
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
Premium
The Fly
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
2M ago
BioCryst’s Strategic Acquisition of ATXS: A Catalyst for Long-Term Growth and Profitability
Premium
Ratings
BioCryst’s Strategic Acquisition of ATXS: A Catalyst for Long-Term Growth and Profitability
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100